SGI
WST icon

Summit Global Investments’s West Pharmaceutical WST Stock Holding History

Summit Global Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-587
Closed -$207K – 614
2023
Q4 		$207K Buy
+587
New +$208K 0.01% 492
2022
Q4 		– Sell
-4,148
Closed -$1.02M – 495
2022
Q3 		$1.02M Sell
4,148
-16
-0.4% -$4.87K 0.09% 196
2022
Q2 		$1.26M Buy
+4,164
New +$1.35M 0.11% 187
2022
Q1 		– Sell
-675
Closed -$316K – 571
2021
Q4 		$316K Buy
675
+44
+7% +$18.9K 0.02% 442
2021
Q3 		$268K Sell
631
-11,017
-95% -$4.64M 0.02% 409
2021
Q2 		$4.18M Sell
11,648
-5,834
-33% -$1.93M 0.25% 80
2021
Q1 		$4.93M Buy
+17,482
New +$5M 0.32% 64

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Summit Global Investments's WST Position: Q1 2024 in Review

Summit Global Investments sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 587 shares — an estimated $207K sold.

Summit Global Investments first reported a position in WST in Q1 2021 and held it in 7 quarters. The position peaked at $4.93M in Q1 2021. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Summit Global Investments reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Summit Global Investments sold 587 West Pharmaceutical shares in Q1 2024, an estimated $207K.
  • Summit Global Investments first reported a position in West Pharmaceutical in Q1 2021 and held it in 7 quarters.
  • Summit Global Investments's West Pharmaceutical position peaked at $4.93M in Q1 2021.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Summit Global Investments's 13F filing for Q1 2024, filed 29 Apr 2024.